Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: other routes
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2012
Report date:
2012

Materials and methods

Principles of method if other than guideline:
Rats were administered a single intravenous injection to the tail vein to determine the tolerability of the test substance by the i.v. route.
GLP compliance:
not specified
Limit test:
no

Test material

Constituent 1
Reference substance name:
(2E)-1,1,1,2,3,4,5,5,6,6,7,7,7-tridecafluoro-4-methoxyhept-2-ene; (3E)-1,1,1,2,2,3,4,5,6,6,7,7,7-tridecafluoro-5-methoxyhept-3-ene; (3E)-1,1,1,2,2,4,5,5,6,6,7,7,7-tridecafluoro-3-methoxyhept-3-ene
EC Number:
700-755-2
Molecular formula:
C8H3F13O
IUPAC Name:
(2E)-1,1,1,2,3,4,5,5,6,6,7,7,7-tridecafluoro-4-methoxyhept-2-ene; (3E)-1,1,1,2,2,3,4,5,6,6,7,7,7-tridecafluoro-5-methoxyhept-3-ene; (3E)-1,1,1,2,2,4,5,5,6,6,7,7,7-tridecafluoro-3-methoxyhept-3-ene
Details on test material:
- Purity: 99.3%

Test animals

Species:
rat
Strain:
other: Crl:CD(SD)
Sex:
male/female

Administration / exposure

Route of administration:
intravenous
Vehicle:
other: ethanol/PEG 400 (20:80)
Doses:
0, 1, 5 mg/kg
No. of animals per sex per dose:
2
Control animals:
yes

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
other: NOEL
Effect level:
5 mg/kg bw
Based on:
test mat.
Remarks on result:
other: highest dose tested; no adverse effects observed

Applicant's summary and conclusion

Conclusions:
No deaths, clinical signs, or body weight losses were oberved in rats at 1 or 5 mg/kg.
Executive summary:

Rats were administered a single intravenous injection of the test substance at 1 or 5 mg/kg to the tail vein. Animals were observed for 4 days after test substance administration. No deaths, clinical signs, or body weight losses were observed at 1 or 5 mg/kg. Under the conditions of the study, the no adverse effect level (NOEL) was 5 mg/kg (the highest dose tested).